Realm Therapeutics - First Patient Dosed in Phase 2 Study of PR022

December 5, 2017
RNS Number : 3601Y
Realm Therapeutics PLC
05 December 2017
 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RESFSLEFLFWSEDE

Search Investor Relations